BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 38664305)

  • 1. Increased LACTB2 Expression Regulates Oxidative Phosphorylation and mTORC1 Signaling of Colorectal Cancer.
    Li H; Wen JY; Liu CZ; Fang YY; Ye YP; Zeng DT; Pan YF; Chen ZX; Liu LM; Song R
    Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38664305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the prognostic value of LACTB2 and its correlation with immune infiltrates in ovarian cancer by integrated bioinformatics analyses.
    Cao W; Wang C; Zhang Y; Yang J; Luo X; Zhao Y; Wu M; Cheng S; Wang Y
    Eur J Med Res; 2024 Mar; 29(1):166. PubMed ID: 38475882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
    Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
    Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
    Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
    Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA.
    Liu XS; Yang JW; Zeng J; Chen XQ; Gao Y; Kui XY; Liu XY; Zhang Y; Zhang YH; Pei ZJ
    Front Cell Dev Biol; 2022; 10():853596. PubMed ID: 35399515
    [No Abstract]   [Full Text] [Related]  

  • 6. RNA demethylase ALKBH5 suppresses tumorigenesis via inhibiting proliferation and invasion and promoting CD8
    Ge J; Liu SL; Zheng JX; Shi Y; Shao Y; Duan YJ; Huang R; Yang LJ; Yang T
    Transl Oncol; 2023 Aug; 34():101683. PubMed ID: 37224767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalised neoantigen-based therapy in colorectal cancer.
    Zhu YJ; Li X; Chen TT; Wang JX; Zhou YX; Mu XL; Du Y; Wang JL; Tang J; Liu JY
    Clin Transl Med; 2023 Nov; 13(11):e1461. PubMed ID: 37921274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant Immune Checkpoint Inhibitor Therapy for Localized Deficient Mismatch Repair Colorectal Cancer: A Review.
    Emiloju OE; Sinicrope FA
    JAMA Oncol; 2023 Dec; 9(12):1708-1715. PubMed ID: 37676680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Profiling Provides Clinical Insights Into Targeted and Immunotherapies as Well as Colorectal Cancer Prognosis.
    Guo L; Wang Y; Yang W; Wang C; Guo T; Yang J; Shao Z; Cai G; Cai S; Zhang L; Hu X; Xu Y
    Gastroenterology; 2023 Aug; 165(2):414-428.e7. PubMed ID: 37146911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses.
    Cui C; Wang J; Fagerberg E; Chen PM; Connolly KA; Damo M; Cheung JF; Mao T; Askari AS; Chen S; Fitzgerald B; Foster GG; Eisenbarth SC; Zhao H; Craft J; Joshi NS
    Cell; 2021 Dec; 184(25):6101-6118.e13. PubMed ID: 34852236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut microbial diversity of colon cancer patients and the clinical significance.
    He T; Cheng X; Xing C
    Bioengineered; 2021 Dec; 12(1):7046-7060. PubMed ID: 34551683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LACTB2 renders radioresistance by activating PINK1/Parkin-dependent mitophagy in nasopharyngeal carcinoma.
    Chen Q; Zheng W; Zhu L; Liu H; Song Y; Hu S; Bai Y; Pan Y; Zhang J; Guan J; Shao C
    Cancer Lett; 2021 Oct; 518():127-139. PubMed ID: 34271102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyst(e)ine in nutrition formulation promotes colon cancer growth and chemoresistance by activating mTORC1 and scavenging ROS.
    Wu J; Yeung SJ; Liu S; Qdaisat A; Jiang D; Liu W; Cheng Z; Liu W; Wang H; Li L; Zhou Z; Liu R; Yang C; Chen C; Yang R
    Signal Transduct Target Ther; 2021 May; 6(1):188. PubMed ID: 34045438
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.